CD36 was also enriched in the “role of adipose tissue hypoxia in obesity and type 2 diabetes” pathway, and it is a shared target of LXR, PXR, and PPAR-gamma (Yin et al., 2009). Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.